Hematopoietic Stem Cell Homing to Injured Tissues
- 726 Downloads
The use of stem cells is considered a promising therapy for tissue regeneration and repair, particularly for tissues injured through degeneration, ischemia and inflammation. Bone marrow (BM)-derived haematopoietic stem cells (HSCs) are rare populations of multipotent stem cells that have been identified as promising potential candidates for treating a broad range of conditions. Although research into the use of stem cells for regenerative medicine is on a steep upward slope, clinical success has not been as forthcoming. This has been primarily attributed to a lack of information on the basic biology of stem cells, which remains insufficient to justify clinical studies. In particular, while our knowledge on the molecular adhesive mechanisms and local environmental factors governing stem cell homing to BM is detailed, our understanding of the mechanisms utilized at injured sites is very limited. For instance, it is unclear whether mechanisms used at injured sites are location specific or whether this recruitment can be modulated for therapeutic purposes. In addition, it has recently been suggested that platelets may play an important role in stem cell recruitment to sites of injury. A better understanding of the mechanisms used by stem cells during tissue homing would allow us to develop strategies to improve recruitment of these rare cells. This review will focus on the status of our current understanding of stem cell homing to injured tissues, the role of platelets and directions for the future.
KeywordsCell adhesion Cell recruitment Hematopoietic stem cells Stem cells Cell trafficking Platelets
DPJK is supported by the British Heart Foundation (PG/08/043). The work from our group detailed in this article was supported by grants from the British Heart Foundation (PG/08/043) and The Royal Society.
Conflict of Interest
The authors declare that there is no conflict of interest regarding the preparation or content of this article.
- 7.Ehnert, S., Glanemann, M., Schmitt, A., et al. (2009). The possible use of stem cells in regenerative medicine: dream or reality? Langenbeck's archives of surgery/Deutsche Gesellschaft fur Chirurgie.Google Scholar
- 16.Civin, C. I., Strauss, L. C., Brovall, C., Fackler, M. J., Schwartz, J. F., & Shaper, J. H. (1984). Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. Journal of Immunology, 133, 157–165.Google Scholar
- 22.Dalakas, E., Newsome, P. N., Liu, Q., et al. (2003). Mobilization of pluripotent haematopoietic stem cells occurs in alcoholic hepatitis and is associated with an improved clinical outcome. In. 55th Annual Meeting of the American Association for the Study of Liver Diseases. Hepatology, 284A.Google Scholar
- 28.Kucia, M., Ratajczak, J., Reca, R., Janowska-Wieczorek, A., & Ratajczak, M. Z. (2004). Tissue-specific muscle, neural and liver stem/progenitor cells reside in the bone marrow, respond to an SDF-1 gradient and are mobilized into peripheral blood during stress and tissue injury. Blood Cells, Molecules & Diseases, 32, 52–57.CrossRefGoogle Scholar
- 39.Levesque, J. P., Takamatsu, Y., Nilsson, S. K., Haylock, D. N., & Simmons, P. J. (2001). Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood, 98, 1289–1297.PubMedCrossRefGoogle Scholar
- 40.Nakano, Y., Kondo, T., Matsuo, R., Murata, S., Fukunaga, K., & Ohkohchi, N. (2009). Prevention of leukocyte activation by the neutrophil elastase inhibitor, sivelestat, in the hepatic microcirculation after ischemia-reperfusion. The Journal of Surgical Research, 155, 311–317.PubMedCrossRefGoogle Scholar
- 46.Mazo, I. B., Gutierrez-Ramos, J., Frenette, P. S., Hynes, R. O., Wagner, D. D., & von Andrian, U. H. (1998). Hematopoietic progenitor cell rolling in bone marrow microvessels: Parrallel contributions by endothelial selectins and vascular cell adhesion molecule 1. The Journal of Experimental Medicine, 188, 465–474.PubMedCrossRefGoogle Scholar
- 47.Frenette, P. S., Subbarao, S., Mazo, I. B., von Andrian, U. H., & Wagner, D. D. (1998). Endothelial selectins and vascular cell adhesion molecule-1 promote hematopoietic progenitor homing to bone marrow. Proceedings of the National Academy of Sciences of the United States of America, 95, 14423–14428.PubMedCrossRefGoogle Scholar
- 55.Papayannopoulou, T., Craddock, C., Nakamoto, B., Priestley, G. V., & Wolf, N. S. (1995). The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proceedings of the National Academy of Sciences of the United States of America, 92, 9647–9651.PubMedCrossRefGoogle Scholar
- 60.Kavanagh, D. P. J., Zhao, Y., Yemm, A. I., & Kalia, N. (2010). Mechansisms of hematopoeitic stem cell recruitment to injured Gut and Muscular microcircualtion [abstract]. Microcirculation, 17, 458–493.Google Scholar
- 62.White, R. L., Mann, J., Kavanagh, D. P. J., Savage, C. O. S., & Kalia, N. (2010). Modulating the adhesion of Hematopoietic stem cells to ischemia-reperfusion injured kidney sections and identifictaion of the molecular mechanisms governing their adhesion [abstract]. Microcirculation, 17, 458–493.Google Scholar
- 68.Kavanagh, D. P. J. (2010). Molecular events governing hematopoietic stem cell recruitment in vivo in murine liver following Ischemia-reperfusion injury [PhD Thesis]: University of Birmingham. Accessible from http://etheses.bham.ac.uk/363/1/Kavanagh09PhD.pdf
- 70.Tarnowski, M., Liu, R., Wysoczynski, M., Ratajczak, J., Kucia, M., & Ratajczak, M. Z. (2010). CXCR7: a new SDF-1-binding receptor in contrast to normal CD34(+) progenitors is functional and is expressed at higher level in human malignant hematopoietic cells. European Journal of Haematology, 85, 472–483.PubMedCrossRefGoogle Scholar
- 73.Hartmann, T. N., Grabovsky, V., Pasvolsky, R., et al. (2008). A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells. Journal of Leukocyte Biology, 84, 1130–1140.PubMedCrossRefGoogle Scholar
- 74.Sierro, F., Biben, C., Martinez-Munoz, L., et al. (2007). Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proceedings of the National Academy of Sciences of the United States of America, 104, 14759–14764.PubMedCrossRefGoogle Scholar
- 81.de Boer, H. C., Verseyden, C., Ulfman, L. H., et al. (2006). Fibrin and activated platelets cooperatively guide stem cells to a vascular injury and promote differentiation towards an endothelial cell phenotype. Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 1653–1659.PubMedCrossRefGoogle Scholar